 |
||||
|
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, April 27, 2005, 25(17):4375-4384; doi:10.1523/JNEUROSCI.0115-05.2005
Previous Article | Next Article
Behavioral/Systems/Cognitive
Identification of Glyoxalase-I as a Protein Marker in a Mouse Model of Extremes in Trait Anxiety
Simone A. Krömer, Melanie S. Keßler, Dale Milfay, Isabel N. Birg, Mirjam Bunck, Ludwig Czibere, Markus Panhuysen, Benno Pütz, Jan M. Deussing, Florian Holsboer, Rainer Landgraf, andChristoph W. Turck Max-Planck Institute of Psychiatry, D-80804 Munich, Germany
For >15 generations, CD1 mice have been selectively and bidirectionally bred for either high-anxiety-related behavior (HAB-M) or low-anxiety-related behavior (LAB-M) on the elevated plus-maze. Independent of gender, HAB-M were more anxious than LAB-M animals in a variety of additional tests, including those reflecting risk assessment behaviors and ultrasound vocalization, with unselected CD1 "normal" control (NAB-M) and cross-mated (CM-M) mice displaying intermediate behavioral scores in most cases. Furthermore, in both the forced-swim and tail-suspension tests, LAB-M animals showed lower scores of immobility than did HAB-M and NAB-M animals, indicative of a reduced depression-like behavior. Using proteomic and microarray analyses, glyoxalase-I was identified as a protein marker, which is consistently expressed to a higher extent in LAB-M than in HAB-M mice in several brain areas. The same phenotype-dependent difference was found in red blood cells with NAB-M and CM-M animals showing intermediate expression profiles of glyoxalase-I. Additional studies will examine whether glyoxalase-I has an impact beyond that of a biomarker to predict the genetic predisposition to anxiety- and depression-like behavior.
Key words: anxiety; enzyme; biomarker; proteomics; HAB; depression; animal model; microarray
Received Aug 6, 2004; revised March 8, 2005; accepted March 9, 2005.
This article has been cited by other articles:
C. Paul, F. Schoberl, P. Weinmeister, V. Micale, C. T. Wotjak, F. Hofmann, and T. Kleppisch
Signaling through cGMP-Dependent Protein Kinase I in the Amygdala Is Critical for Auditory-Cued Fear Memory and Long-Term Potentiation
J. Neurosci., December 24, 2008; 28(52): 14202 - 14212.
[Abstract] [Full Text] [PDF]
R. Marsch, E. Foeller, G. Rammes, M. Bunck, M. Kossl, F. Holsboer, W. Zieglgansberger, R. Landgraf, B. Lutz, and C. T. Wotjak
Reduced Anxiety, Conditioned Fear, and Hippocampal Long-Term Potentiation in Transient Receptor Potential Vanilloid Type 1 Receptor-Deficient Mice
J. Neurosci., January 24, 2007; 27(4): 832 - 839.
[Abstract] [Full Text] [PDF]
C. Ditzen, A. M. Jastorff, M. S. Kessler, M. Bunck, L. Teplytska, A. Erhardt, S. A. Kromer, J. Varadarajulu, B.-S. Targosz, E. F. Sayan-Ayata, et al.
Protein Biomarkers in a Mouse Model of Extremes in Trait Anxiety
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1914 - 1920.
[Abstract] [Full Text] [PDF]
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke
Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
J. Neurosci., May 10, 2006; 26(19): 5167 - 5179.
[Abstract] [Full Text] [PDF]
O. J. Bosch, S. L. Meddle, D. I. Beiderbeck, A. J. Douglas, and I. D. Neumann
Brain Oxytocin Correlates with Maternal Aggression: Link to Anxiety
J. Neurosci., July 20, 2005; 25(29): 6807 - 6815.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|